2A Biosciences, Inc. — Form D/A
2A Biosciences, Inc. of SANTA MONICA, CA, a company, filed a Form D amendment with the SEC on 2023-07-27. The offering totals $5.5M, of which $3.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-07-27
- Form: D/A
- Accession: 0001567619-23-006698
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.5M
- Amount sold: $3.8M
- Remaining: $1.7M
- Investors: 13
- Date of first sale: 2023-03-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-475787
Issuer
- Name: 2A Biosciences, Inc.
- CIK: 0001968754
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 2A Biosciences, Inc., SANTA MONICA, CA, 90405
- Phone: (917) 757-1051
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Gopal Paul Das | Director | San Diego, CA |
| Timothy Paul Foster | Director | Santa Monica, CA |
| Charles David Nichols | Director | Santa Monica, CA |
| David Earl Nichols | Director | Santa Monica, CA |
| Alexander Speiser | Director | Santa Monica, CA |
| Timothy Paul Foster | Executive Officer | Santa Monica, CA |
| Charles David Nichols | Executive Officer | Santa Monica, CA |
| David Earl Nichols | Executive Officer | Santa Monica, CA |
| Alexander Speiser | Executive Officer | Santa Monica, CA |
| Gene Bradley Ramirez | Director | Santa Monica, CA |
| Gene Bradley Ramirez | Executive Officer | Santa Monica, CA |
Other filings by this issuer (1)
More